AquaVita NextGen review
Each molecule is sold as a one-month supply at a single published price, with no dose named beside it.
The verdict
Aquavita NextGen publishes $215 for a one-month supply of compounded semaglutide and $320 for tirzepatide, and nothing on the pages says what dose either figure covers.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 5
- From
- From $215/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Aquavita NextGen sells both molecules by injection, one month at a time, and the catalog is short enough that the two product pages are the whole of what a buyer has to go on before a first order.
Who writes the prescription, and what do they see?
A prescription is issued before anything ships, and the published pages describe products and rates rather than the clinician who writes it, so nothing here says what is reviewed before a first order or a fifth.
Remote and price-led, with the two molecule lines carrying the whole of what the site says about itself, and no description of a course of care running underneath them.
What happens when the dose goes up?
Nothing on the pages states what either figure covers in milligrams, so a buyer climbing from a starting dose toward a maintenance one cannot tell from the shop whether the $215 follows them up the ladder. That question belongs in the intake, before the second month rather than after it.
What the price includes
At $215 a month, six months of semaglutide is $1,290, and tirzepatide at $320 runs to $1,920 over the same span. Those totals hold only if the one-month price holds at every dose, which the pages neither promise nor rule out, so the figure is worth confirming on the seller's own page before a first charge.
What it claims, and what it cites
Both lines are compounded rather than manufactured, prepared by a pharmacy the site does not name, and not reviewed by the FDA before dispensing as an approved product would be.
Where it holds up, and where it does not
- Strength: Each price is tied to a one-month supply
- Strength: Both molecules carry a published price
- Limitation: No care program is described beside the drug
- Limitation: No milligram dose beside either figure
- Limitation: Nothing published about dose pricing
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about AquaVita NextGen. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants a one-month price with no plan attached and will confirm the dose it covers.
- Wrong for
- A reader who needs the cost at a maintenance dose settled before ordering.
The evidence behind what AquaVita NextGen prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How AquaVita NextGen compares
| Seller | Who it suits | Go |
|---|---|---|
 ARSYNL Rx | Readers who want both molecules priced on one page and will confirm the figure on the day | See ARSYNL Rx → |
 Clume Health | Readers who want both molecules at one rate and will re-check the figure before paying | See Clume Health → |
| Candor Rx | Readers who value a bill that does not move with the dose and will confirm the figure first | See Candor Rx → |
More GLP-1 telehealth sellers reviews: Fifty 410FitFlowFitishFitness RXFitRxFitstry
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What does semaglutide cost?
- $215 for a one-month supply, the figure printed on both the shop grid and the product page.
- Does the price change with the dose?
- The pages do not say, because neither product lists a milligram figure beside its price, so the question belongs in the intake before a first charge rather than after it.
- What about tirzepatide?
- That line is $320 a month, and nothing on the pages states what dose either figure covers.
- Is AquaVita NextGen expensive compared with other GLP-1 telehealth sellers?
- AquaVita NextGen publishes a starting figure of $215/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts AquaVita NextGen above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.